Anthony Addlagatta

Anthony Addlagatta

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2015 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
AKAhmed Kamal
Ahmed Kamal
ASAnver Basha Shaik
Anver Basha Shaik
NJNishant Jain
Nishant Jain
CKChandan Kishor
Chandan Kishor
ANAnanthamurthy Nagabhushana
Ananthamurthy Nagabhushana
AAAnthony Addlagatta
Anthony Addlagatta

2 September 2011 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MRM. Amarnath Reddy
M. Amarnath Reddy
NJNishant Jain
Nishant Jain
DYDeepthi Yada
Deepthi Yada
CKChandan Kishor
Chandan Kishor
JVJanakiram Reddy Vangala
Janakiram Reddy Vangala
BSBojja Sreedhar
Bojja Sreedhar

28 September 2012 in Medicinal Chemistry Research
Verified
Journal Article
Closed access
PDF file
SBS. Bhavanarushi
S. Bhavanarushi
VKV. Kanakaiah
V. Kanakaiah
EYE. Yakaiah
E. Yakaiah
VSV. Saddanapu
V. Saddanapu
AAAnthony Addlagatta
Anthony Addlagatta
JRJetti Vatsala Rani
Jetti Vatsala Rani

12 January 2012 in ChemMedChem
Verified
Journal Article
Closed access
PDF file
AKAhmed Kamal
Ahmed Kamal
FSFarheen Sultana
Farheen Sultana
MRM. Janaki Ramaiah
M. Janaki Ramaiah
YSY. V. V. Srikanth
Y. V. V. Srikanth
AVA. Viswanath
A. Viswanath
MBManika Pal Bhadra
Manika Pal Bhadra

23 September 2013 in ChemMedChem
Verified
Journal Article
Closed access
PDF file
AKAhmed Kamal
Ahmed Kamal
VRVangala Santhosh Reddy
Vangala Santhosh Reddy
SKSantosh Karnewar
Santosh Karnewar
SCSumit S. Chourasiya
Sumit S. Chourasiya
ASAnver Basha Shaik
Anver Basha Shaik
SKSrigiridhar Kotamraju
Srigiridhar Kotamraju

2 February 2015 in Protein Science
Verified
Journal Article
Open access
PDF file
RGRoopa Jones Ganji
Roopa Jones Ganji
RRRavikumar Reddi
Ravikumar Reddi
RGRajesh Gumpena
Rajesh Gumpena
AMAnil Kumar Marapaka
Anil Kumar Marapaka
TATarun Arya
Tarun Arya
AAAnthony Addlagatta
Anthony Addlagatta
Actinonin is a pseudotripeptide that displays a high affinity towards metalloproteases including peptide deformylases (PDFs) and M1 family aminopeptidases. PDF and M1 family aminopeptidases belong to thermolysin‐metzincin superfamily. One of the major differences in terms of substrate binding pockets between these families is presence (in M1 aminopeptidases) or absence (in PDFs) of an S1 substrate pocket. The binding mode of actinonin to PDFs has been established previously; however, it is not clear how the actinonin, without a P1 residue, would bind to the M1 aminopeptidases. Here we describe the crystal structure of Escherichia coli aminopeptidase N (ePepN), a model protein of the M1 family aminopeptidases in complex with actinonin. For comparison we have also determined the structure of ePepN in complex with a well‐known tetrapeptide inhibitor, amastatin. From the comparison of the actinonin and amastatin ePepN complexes, it is clear that the P1 residue is not critical as long as strong metal chelating head groups, like hydroxamic acid or α‐hydroxy ketone, are present. Results from this study will be useful for the design of selective and efficient hydroxamate inhibitors against M1 family aminopeptidases.